Coxsackieviral replication and pathogenicity: lessons from gene modified animal models
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 193 (2) , 71-74
- https://doi.org/10.1007/s00430-003-0203-0
Abstract
Coxsackieviruses have been implicated in the pathogenesis of human myocarditis and some forms of dilated cardiomyopathy. A considerable portion of our knowledge about the pathophysiology of viral heart disease is derived from animal studies. In particular, investigations utilising gene-targeted mice provide valuable new insights into various aspects of viral pathogenicity and host factors involved in the control of viral replication. This review focuses on models in cell culture and transgenic animals mimicking coxsackieviral persistence, demonstrating that remarkably low persisting levels of replication-restricted coxsackieviral genomes are associated with an induction of a cytopathic effect in cardiac myocytes, leading to dilated cardiomyopathy in a transgenic mouse model. In this particular animal model, a phenotype is revealed which closely resembles the major hallmarks of human dilated cardiomyopathy. The impact of the innate immune system on coxsackieviral replication is demonstrated by studies in gene-targeted mice deficient of either type I or type II interferon signalling, which have indicated that type I but not type II interferons are essential for the control of early viral replication and survival of coxsackieviral infection.Keywords
This publication has 25 references indexed in Scilit:
- Absence of viral nucleic acids in early and late dilated cardiomyopathyHeart, 2001
- The group B coxsackieviruses and myocarditisReviews in Medical Virology, 2001
- Apoptosis in Coxsackievirus B3-Caused Diseases: Interaction between the Capsid Protein VP2 and the Proapoptotic Protein SivaJournal of Virology, 2000
- Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.Journal of Clinical Investigation, 1998
- Low-Level Expression of a Mutant Coxsackieviral cDNA Induces a Myocytopathic Effect in CultureCirculation, 1998
- Subclassification of dilated cardiomyopathy and interferon treatmentEuropean Heart Journal, 1995
- Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic MiceJournal of Biological Chemistry, 1995
- Synergistic Interaction of Interferon- and Interferon- in Coxsackievirus B3-Infected Carrier Cultures of Human Myocardial FibroblastsThe Journal of Infectious Diseases, 1992
- Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.Proceedings of the National Academy of Sciences, 1992
- Viral myocarditis. A review.1980